After market close, Harrow (HROW) reported Q3 revenue of $49.3 million, with a net loss of $0.12 per share and adjusted loss ...
Harrow Cares delivers a comprehensive suite of ... today announced positive topline results of its pivotal Phase 3 study evaluating the safety and efficacy of its lead product candidate, MELT ...
As the U.S. stock market continues its upward trajectory, buoyed by strong earnings reports and investor optimism, major indices like the Dow Jones Industrial Average and the S&P 500 are approaching ...